This study demonstrated that PCSK9 levels at or above 370 ng/ml significantly increase the risk of 28-day mortality in sepsis, providing evidence to evaluate the potential clinical significance of circulating PCSK9 in assessing the prognosis of septic. This evidence concerns the gene PCSK9 and Sepsis.